Related Experiment Video
Updated: May 11, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.3K
Establishing a New Left Ventricular Assist Device Program: From Concept to Reality.
Ehud Jacobzon1, Avital Lifschitz1, Danny Fink1
1Department of Cardiothoracic Surgery, Shaare Zedek Medical Center, Jerusalem, Israel.
The Israel Medical Association Journal : IMAJ
|June 17, 2024
Summary
Establishing a new left ventricular assist device (LVAD) program in non-transplant centers is feasible. Careful planning and patient selection lead to successful outcomes for advanced heart failure patients.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Device Technology
Background:
- Left ventricular assist devices (LVADs) are crucial for advanced heart failure treatment.
- LVAD implantation is typically performed at heart transplant centers.
- LVADs serve as destination therapy or a bridge to heart transplantation.
Purpose of the Study:
- To detail the process of establishing a novel LVAD program at a non-heart transplant center.
- To present the initial short- and long-term outcomes of the first 25 LVAD patients.
Main Methods:
- Program establishment involved needs assessment, team formation, and protocol development (pre-operative, intra-operative, post-operative, outpatient).
- Collaboration with an established heart transplant center was initiated early.
- Emphasis was placed on meticulous patient selection, initially focusing on lower-risk individuals.
Main Results:
- The study analyzed the first 25 LVAD patients.
- The initial five patients survived over two years without major complications.
- One operative death occurred due to gastrointestinal bleeding; four late deaths resulted from septic events.
Conclusions:
- Successful LVAD program implementation is achievable in smaller and medium-sized centers.
- Meticulous planning facilitates the expansion of LVAD implantation to more facilities.
- LVADs offer a viable treatment option for a broader range of advanced heart failure patients.

